Geographical variability and environmental risk factors in inflammatory bowel disease

Gut

Volumn 62, Issue 4, 2013, Pages 630-649

  Ng, Siew C ^a   Bernstein, Charles N ^b   Vatn, Morten H ^c   Lakatos, Peter Laszlo ^d   Loftus Jr , Edward V ^e   Tysk, Curt ^f   O'Morain, Colm ^g   Moum, Bjorn ^c   Colombel, Jean Frédéric ^h  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF OSLO   (Norway)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e MAYO CLINIC   (United States)

^f ÖREBRO UNIVERSITY   (Sweden)

^g ADELAIDE AND MEATH HOSPITAL   (Ireland)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APPENDECTOMY; ARTICLE; DEVELOPING COUNTRY; DIETARY INTAKE; ENTERITIS; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; GEOGRAPHY; HUMAN; HYGIENE; INCIDENCE; INDUSTRIALIZATION; LIFESTYLE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SOCIAL STATUS; ULCERATIVE COLITIS;

ENVIRONMENTAL EXPOSURE; GEOGRAPHY; HUMANS; INFLAMMATORY BOWEL DISEASES; RISK FACTORS;

EID: 84874652518     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303661     Document Type: Article

References (197)

1. Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol 1995;30(Suppl. 8):1-4.
2. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 2008;14:542-9. (Pubitemid 351571835)
3. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008;57:1185-91.
4. Thia KT, Loftus EV Jr, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167-82.
5. Probert CS, Jayanthi V, Pinder D, et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992;33:687-93.
6. Smith LA, Rameshanker R, Healy J. An unusual prevalence of inflammatory bowel disease in a multiethnic population-single centre UK data. Gut 2010;59(suppl. III):A181.
7. Barreiro-de AM, Alvarez CA, Souto R, et al. Emigration to western industrialized countries: a risk factor for developing inflammatory bowel disease. J Crohns Colitis 2011;5:566-9.
8. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
9. Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011;17:423-39.
10. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011;140:1785-94.
11. Gearry RB, Richardson AK, Frampton CM, et al. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010;25:325-33.
12. Wilson J, Hair C, Knight R, et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis 2010;16:1550-6.
13. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results: of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690-7. (Pubitemid 26426470)
14. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn Colitis Database. Am J Gastroenterol 2006;101:1274-82. (Pubitemid 43833122)
15. Lakatos L, Mester G, Erdelyi Z, et al. (Epidemiology of inflammatory bowel diseases in Veszprem county of Western Hungary between 1977 and 2001). Orv Hetil 2003;144:1819-27.
16. Lakatos L, Kiss LS, David G, et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011;17:2558-65.
17. Sincic BM, Vucelic B, Persic M, et al. Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: a prospective population-based study. Scand J Gastroenterol 2006;41:437-44. (Pubitemid 43675410)
18. Gheorghe C, Pascu O, Gheorghe L, et al. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study. Eur J Gastroenterol Hepatol 2004;16:1153-9. (Pubitemid 39488787)
19. Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, et al. Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland. World J Gastroenterol 2005;11:2630-3. (Pubitemid 40704281)
20. Frangos CC, Frangos CC. Inflammatory bowel disease: reviewing an old study under a new perspective. Gut 2007;56:1638-9. (Pubitemid 350033207)
21. Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996;31:362-6. (Pubitemid 26119616)
22. Nerich V, Monnet E, Etienne A, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 2006;12:218-26.
23. Blanchard JF, Bernstein CN, Wajda A, et al. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001;154:328-35. (Pubitemid 32756629)
24. Green C, Elliott L, Beaudoin C, et al. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 2006;164:615-23. (Pubitemid 44453488)
25. Armitage EL, Aldhous MC, Anderson N, et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004;127:1051-7. (Pubitemid 39345874)
26. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994;35:1433-8. (Pubitemid 24310907)
27. Molinie F, Gower-Rousseau C, Yzet T, et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 2004;53:843-8. (Pubitemid 38662134)
28. Declercq C, Gower-Rousseau C, Vernier-Massouille G, et al. Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence. Inflamm Bowel Dis 2010;16:807-12.
29. Nerich V, Monnet E, Weill A, et al. Fine-scale geographic variations of inflammatory bowel disease in France: correlation with socioeconomic and house equipment variables. Inflamm Bowel Dis 2010;16:813-21.
30. Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991;100:350-8.
31. Haug K, Schrumpf E, Halvorsen JF, et al. Epidemiology of Crohn's disease in western Norway. Study group of Inflammatory Bowel Disease in Western Norway. Scand J Gastroenterol 1989;24:1271-5.
32. Kildebo S, Breckan R, Nordgaard K, et al. The incidence of Crohn's disease in northern Norway from 1983 to 1986. Northern Norway Gastroenterology Society. Scand J Gastroenterol 1989;24:1265-70. (Pubitemid 20015807)
33. Soon IS, Molodecky NA, Rabi DM, et al. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol 2012;12:51.
34. Duggan AE, Usmani I, Neal KR, et al. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case-control study. Gut 1998;43:494-8. (Pubitemid 28462034)
35. Calkins BM, Lilienfeld AM, Garland CF, et al. Trends in incidence rates of ulcerative colitis and Crohn's disease. Dig Dis Sci 1984;29:913-20. (Pubitemid 14021795)
36. Garland CF, Lilienfeld AM, Mendeloff AI, et al. Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States. Gastroenterology 1981;81:1115-24. (Pubitemid 11029694)
37. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006;101:1559-68. (Pubitemid 43980630)
38. Martin-de-Carpi J, Rodriguez A, Ramos E, et al. Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT registry. Inflamm Bowel Dis Published Online First: 25 Apr. 2012. doi: 10.1002/ibd.22980
39. Chouraki V, Savoye G, Dauchet L, et al. The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10 to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 2011;33:1133-42.
40. Zheng JJ, Shi XH, Zhu XS, et al. (A comparative study of incidence and prevalence of Crohn's disease in mainland China in different periods). Zhonghua Nei Ke Za Zhi 2011;50:597-600.
41. Zheng JJ, Zhu XS, Huangfu Z, et al. Crohn's disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis 2005;6:175-81.
42. Zheng JJ, Zhu XS, Huangfu Z, et al. Prevalence and incidence rates of Crohn's disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis 2010;11:161-6.
43. Desai HG, Gupte PA. Increasing incidence of Crohn's disease in India: is it related to improved sanitation? Indian J Gastroenterol 2005;24:23-4. (Pubitemid 40379923)
44. Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000;43(10 Suppl.):S85-93.
45. Lok KH, Hung HG, Ng CH, et al. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J Gastroenterol Hepatol 2008;23:406-10.
46. Thia KT, Luman W, Jin OC. Crohn's disease runs a more aggressive course in young Asian patients. Inflamm Bowel Dis 2006;12:57-61. (Pubitemid 43032453)
47. Jiang L, Xia B, Li J, et al. Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study. J Clin Gastroenterol 2007;41:280-4. (Pubitemid 46340750)
48. Tezel A, Dokmeci G, Eskiocak M, et al. Epidemiological features of ulcerative colitis in Trakya, Turkey. J Int Med Res 2003;31:141-8. (Pubitemid 36553313)
49. Hilmi I, Singh R, Ganesananthan S, et al. Demography and clinical course of ulcerative colitis in a multiracial Asian population: a nationwide study from Malaysia. J Dig Dis 2009;10:15-20.
50. Tan YM, Goh KL. Ulcerative colitis in a multiracial Asian country: racial differences and clinical presentation among Malaysian patients. World J Gastroenterol 2005;11:5859-62.
51. Juyal G, Prasad P, Senapati S, et al. An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. PLoS One 2011;6:e16565.
52. Ott C, Obermeier F, Thieler S, et al. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol 2008;20:917-23.
53. Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 2006;12:6102-8. (Pubitemid 44688157)
54. Lehtinen P, Ashorn M, Iltanen S, et al. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987-2003, a nationwide study. Inflamm Bowel Dis 2011;17:1778-83.
55. Lakatos PL, Lakatos L, Szalay F, et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J Gastroenterol 2005;11:1489-95. (Pubitemid 40468084)
56. Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J Dig Dis 2010;11:76-82.
57. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992;33:779-82.
58. Russel MG, Volovics A, Schoon EJ, et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 1998;4:182-6. (Pubitemid 128699851)
59. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006;81:1462-71. (Pubitemid 44687433)
60. Holm H, Jarvis MJ, Russell MA, et al. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl) 1992;108:507-11.
61. Carlens C, Hergens MP, Grunewald J, et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med 2010;181:1217-22.
62. Reif S, Klein I, Arber N, et al. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology 1995;108:1683-7.
63. Reif S, Lavy A, Keter D, et al. Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol 2000;95:474-8. (Pubitemid 30106179)
64. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996;110:424-31. (Pubitemid 26043875)
65. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004;10:646-51. (Pubitemid 39276475)
66. Prideaux L, Kamm MA, De CP, et al. Comparison of Clinical Characteristics and Management of Inflammatory Bowel Disease in Hong Kong versus Melbourne. J Gastroenterol Hepatol 2012;27:919-27.
67. A case-control study of ulcerative colitis in relation to dietary and other factors in Japan. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol 1995;30(Suppl. 8):9-12.
68. Lakatos PL, Vegh Z, Lovasz BD, et al. Is current smoking still an important environmental factor for inflammatory bowel disease? Results: from a population-based incident cohort. Inflamm Bowel Dis 2013. In press.
69. Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 2007;13:6134-9.
70. Bridger S, Lee JC, Bjarnason I, et al. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut 2002;51:21-5. (Pubitemid 34717738)
71. Andersson RE, Olaison G, Tysk C, et al. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001;344:808-14. (Pubitemid 32222158)
72. Lopez-Serrano P, Perez-Calle JL, Perez-Fernandez MT, et al. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand J Gastroenterol 2010;45:1464-71.
73. Naganuma M, Iizuka B, Torii A, et al. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001;96:1123-6. (Pubitemid 32319147)
74. Firouzi F, Bahari A, Aghazadeh R, et al. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: a case-control study in Iran. Int J Colorectal Dis 2006;21:155-9. (Pubitemid 43154435)
75. Radford-Smith GL, Edwards JE, Purdie DM, et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002;51:808-13. (Pubitemid 35408600)
76. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of appendicectomy on the course of ulcerative colitis. Gut 2002;51:803-7. (Pubitemid 35408599)
77. Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol 2000;95:171-6. (Pubitemid 30041554)
78. Kaplan GG, Jackson T, Sands BE, et al. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol 2008;103:2925-31.
79. Frisch M, Gridley G. Appendectomy in adulthood and the risk of inflammatory bowel diseases. Scand J Gastroenterol 2002;37:1175-7. (Pubitemid 35178683)
80. Kurina LM, Goldacre MJ, Yeates D, et al. Appendicectomy, tonsillectomy, and inflammatory bowel disease: a case-control record linkage study. J Epidemiol Community Health 2002;56:551-4. (Pubitemid 34712954)
81. Frisch M, Johansen C, Mellemkjaer L, et al. Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery 2001;130:36-43. (Pubitemid 32626195)
82. Koutroubakis IE, Vlachonikolis IG, Kapsoritakis A, et al. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: case-controlled study in Crete. Dis Colon Rectum 1999;42:225-30. (Pubitemid 29085160)
83. Andersson RE, Olaison G, Tysk C, et al. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 2003;124:40-6. (Pubitemid 36055337)
84. Reif S, Lavy A, Keter D, et al. Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease. Am J Gastroenterol 2001;96:829-32. (Pubitemid 32240739)
85. Rodriguez LA Garcia, Gonzalez-Perez A, Johansson S, et al. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 2005;22:309-15. (Pubitemid 41207460)
86. Russel MG, Dorant E, Brummer RJ, et al. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology 1997;113:377-82. (Pubitemid 27351760)
87. Sicilia B, Lopez MC, Arribas F, et al. Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain. Dig Liver Dis 2001;33:762-7. (Pubitemid 34071467)
88. Kaplan GG, Pedersen BV, Andersson RE, et al. The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Gut 2007;56:1387-92. (Pubitemid 47517832)
89. Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 2002;8:277-86. (Pubitemid 34784981)
90. Mizoguchi A, Mizoguchi E, Chiba C, et al. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med 1996;184:707-15. (Pubitemid 26324124)
91. Mayer L, Eisenhardt D. Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. J Clin Invest 1990;86:1255-60. (Pubitemid 20370432)
92. Roblin X, Neut C, Rfeuille-Michaud A, et al. Local appendiceal dysbiosis: the missing link between the appendix and ulcerative colitis? Gut 2012;61:635-6.
93. Shoda R, Matsueda K, Yamato S, et al. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996;63:741-5. (Pubitemid 26126594)
94. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91. (Pubitemid 34747528)
95. Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005;11:154-63. (Pubitemid 40711220)
96. Nerich V, Jantchou P, Boutron-Ruault MC, et al. Low exposure to sunlight is a risk factor for Crohn's disease. Aliment Pharmacol Ther 2011;33:940-5.
97. Perrin AE, Dallongeville J, Ducimetiere P, et al. Interactions between traditional regional determinants and socio-economic status on dietary patterns in a sample of French men. Br J Nutr 2005;93:109-14.
98. Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochenschr 1976;54:367-71.
99. Riordan AM, Ruxton CH, Hunter JO. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998;52:229-38. (Pubitemid 28159617)
100. Mayberry JF, Rhodes J, Allan R, et al. Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 1981;26:444-8. (Pubitemid 11120733)
101. Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:47-51.
102. Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997;40:754-60. (Pubitemid 27305468)
103. Russel MG, Engels LG, Muris JW, et al. Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998;10:243-9. (Pubitemid 28175002)
104. Tjonneland A, Overvad K, Bergmann MM, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009;58:1606-11.
105. Jantchou P, Morois S, Clavel-Chapelon F, et al. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol 2010;105:2195-201.
106. Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992;3:47-52.
107. Geerling BJ, Dagnelie PC, Badart-Smook A, et al. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000;95:1008-13. (Pubitemid 30196738)
108. Maconi G, Ardizzone S, Cucino C, et al. Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study. World J Gastroenterol 2010;16:4297-304.
109. Logan I, Bowlus CL. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010;9:A372-8.
110. Aamodt G, Bukholm G, Jahnsen J, et al. The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway. Am J Epidemiol 2008;168:1065-72.
111. Andersen V, Olsen A, Carbonnel F, et al. Diet and risk of inflammatory bowel disease. Dig Liver Dis 2012;44:185-94.
112. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007;104:13780-5. (Pubitemid 350003397)
113. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94. (Pubitemid 351173057)
114. Boudeau J, Glasser AL, Masseret E, et al. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 1999;67:4499-509. (Pubitemid 29400425)
115. Rfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405-13. (Pubitemid 28545991)
116. Sepehri S, Kotlowski R, Bernstein CN, et al. Phylogenetic analysis of inflammatory bowel disease associated Escherichia coli and the fimH virulence determinant. Inflamm Bowel Dis 2009;15:1737-45.
117. Chacon O, Bermudez LE, Barletta RG. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol 2004;58:329-63. (Pubitemid 39551990)
118. Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 2007;7:607-13. (Pubitemid 47268226)
119. Ricanek P, Lothe SM, Szpinda I, et al. Paucity of mycobacteria in mucosal bowel biopsies from adults and children with early inflammatory bowel disease. J Crohns Colitis 2010;4:561-6.
120. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Population-based case-control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2004;42:1129-35. (Pubitemid 38332836)
121. Bernstein CN, Wang MH, Sargent M, et al. Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease. J Clin Microbiol 2007;45:968-71. (Pubitemid 46427719)
122. Mpofu CM, Campbell BJ, Subramanian S, et al. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology 2007;133:1487-98. (Pubitemid 350029735)
123. Rfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127:412-21. (Pubitemid 39091889)
124. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93. (Pubitemid 38962277)
125. Sepehri S, Khafipour E, Bernstein CN, et al. Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis 2010.
126. Rfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease. Int J Med Microbiol 2002;292:185-93.
127. Miquel S, Peyretaillade E, Claret L, et al. Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PLoS One 2010;5:e12714.
128. Krause DO, Little AC, Dowd SE, et al. Complete genome sequence of adherent invasive Escherichia coli UM146 isolated from Ileal Crohn's disease biopsy tissue. J Bacteriol 2011;193:583.
129. Luther J, Dave M, Higgins PD, et al. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 2010;16:1077-84.
130. Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol 2008;14:165-73. (Pubitemid 351314294)
131. Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol 2005;39(4 Suppl. 2):S59-65. (Pubitemid 40397017)
132. Hugot JP, Alberti C, Berrebi D, et al. Crohn's disease: the cold chain hypothesis. Lancet 2003;362:2012-15. (Pubitemid 37548429)
133. Forbes A, Kalantzis T. Crohn's disease: the cold chain hypothesis. Int J Colorectal Dis 2006;21:399-401.
134. Malekzadeh F, Alberti C, Nouraei M, et al. Crohn's disease and early exposure to domestic refrigeration. PLoS One 2009;4:e4288.
135. Porter CK, Tribble DR, Aliaga PA, et al. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 2008;135:781-6.
136. Rodriguez LA Garcia, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006;130:1588-94. (Pubitemid 43668828)
137. Gradel KO, Nielsen HL, Schonheyder HC, et al. Increased shortand long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 2009;137:495-501.
138. Jess T, Simonsen J, Nielsen NM, et al. Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease. Gut 2011;60:318-24.
139. Foxman EF, Iwasaki A. Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol 2011;9:254-64.
140. De VB, De CC, Gower-Rousseau C, et al. Editorial: antibiotics earlier, IBD later? Am J Gastroenterol 2010;105:2693-6.
141. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 2010;105:2687-92.
142. Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011;60:49-54.
143. Virta L, Auvinen A, Helenius H, et al. Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease-a nationwide, register-based Finnish case-control study. Am J Epidemiol 2012;175:775-84.
144. Shaw SY Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2011;106:2133-42.
145. Kronman MP, Zaoutis TE, Haynes K, et al. Antibiotic exposure and IBD development among children: a population-based Cohort study. Pediatrics 2012;130:e794-803.
146. Jakobsen C, Paerregaard A, Munkholm P, et al. Paediatric inflammatory bowel disease during a 44-year period in Copenhagen County: occurrence, course and prognosis-a population-based study from the Danish Crohn Colitis Database. Eur J Gastroenterol Hepatol 2009;21:1291-301.
147. Perminow G, Brackmann S, Lyckander LG, et al. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease. Scand J Gastroenterol 2009;44:446-56.
148. Perminow G, Frigessi A, Rydning A, et al. Incidence and clinical presentation of IBD in children: comparison between prospective and retrospective data in a selected Norwegian population. Scand J Gastroenterol 2006;41:1433-9. (Pubitemid 44764404)
149. Gilat T, Hacohen D, Lilos P, et al. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987;22:1009-24. (Pubitemid 17152843)
150. Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci 1994;39:555-60. (Pubitemid 24137343)
151. Card T, Logan RF, Rodrigues LC, et al. Antibiotic use and the development of Crohn's disease. Gut 2004;53:246-50. (Pubitemid 38125513)
152. Ruemmele FM, El Khoury MG, Talbotec C, et al. Characteristics of inflammatory bowel disease with onset during the first year of life. J Pediatr Gastroenterol Nutr 2006;43:603-9. (Pubitemid 44863685)
153. Hildebrand H, Malmborg P, Askling J, et al. Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease. Scand J Gastroenterol 2008;43:961-6.
154. Ananthakrishnan AN, Higuchi LM, Huang ES, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med 2012;156:350-9.
155. Ekbom A, Adami HO, Helmick CG, et al. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol 1990;132:1111-19.
156. Klement E, Lysy J, Hoshen M, et al. Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study 1. Am J Gastroenterol 2008;103:1775-82.
157. Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut 1990;31:1037-40. (Pubitemid 20295942)
158. Montgomery SM, Lambe M, Wakefield AJ, et al. Siblings and the risk of inflammatory bowel disease. Scand J Gastroenterol 2002;37:1301-8. (Pubitemid 35305768)
159. Bengtson MB, Solberg C, Aamodt G, et al. Clustering in time of familial IBD separates ulcerative colitis from Crohn's disease. Inflamm Bowel Dis 2009;15:1867-74.
160. Lashner BA, Loftus EV Jr. True or false? The hygiene hypothesis for Crohn's disease. Am J Gastroenterol 2006;101:1003-4. (Pubitemid 43725313)
161. Bernstein CN, Rawsthorne P, Cheang M, et al. A population-based case-control study of potential risk factors for IBD. Am J Gastroenterol 2006;101:993-1002. (Pubitemid 43725312)
162. Amre DK, Lambrette P, Law L, et al. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol 2006;101:1005-11. (Pubitemid 43725314)
163. Feeney MA, Murphy F, Clegg AJ, et al. A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002;14:529-34. (Pubitemid 34518185)
164. Beamish LA, Osornio-Vargas AR, Wine E. Air pollution: An environmental factor contributing to intestinal disease. J Crohns Colitis 2011;5:279-86.
165. Khalili H, Huang ES, Ananthakrishnan AN, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 2012;61:1686-92.
166. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012;142:482-9.
167. Simpson S Jr, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011;82:1132-41.
168. Aamodt G, Jahnsen J, Bengtson MB, et al. Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990-1993. Inflamm Bowel Dis 2008;14:984-91.
169. Ramcharan S, Pellegrin FA, Ray RM, et al. The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: a comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives. J Reprod Med 1980;25(6 Suppl.):345-72. (Pubitemid 11177497)
170. Logan RF, Kay CR. Oral contraception, smoking and inflammatory bowel disease-findings in the Royal College of General Practitioners Oral Contraception Study. Int J Epidemiol 1989;18:105-7. (Pubitemid 19128640)
171. Vessey M, Jewell D, Smith A, et al. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. BMJ (Clin Res Ed) 1986;292:1101-3. (Pubitemid 16110633)
172. Boyko EJ, Theis MK, Vaughan TL, et al. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol 1994;140:268-78. (Pubitemid 24231913)
173. Corrao G, Tragnone A, Caprilli R, et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol 1998;27:397-404. (Pubitemid 28336965)
174. Lesko SM, Kaufman DW, Rosenberg L, et al. Evidence for an increased risk of Crohn's disease in oral contraceptive users. Gastroenterology 1985;89:1046-9. (Pubitemid 16231568)
175. Katschinski B, Fingerle D, Scherbaum B, et al. Oral contraceptive use and cigarette smoking in Crohn's disease. Dig Dis Sci 1993;38:1596-600. (Pubitemid 23271412)
176. Cornish JA, Tan E, Simillis C, et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008;103:2394-400.
177. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37:668-73.
178. Baron S, Turck D, Leplat C, et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case-control study. Gut 2005;54:357-63. (Pubitemid 40299091)
179. Klement E, Cohen RV, Boxman J, et al. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr 2004;80:1342-52.
180. Mikhailov TA, Furner SE. Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children. World J Gastroenterol 2009;15:270-9.
181. Wakefield AJ, Ekbom A, Dhillon AP, et al. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995;108:911-16.
182. Thompson NP, Montgomery SM, Pounder RE, et al. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995;345:1071-4.
183. Feeney M, Ciegg A, Winwood P, et al. A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group. Lancet 1997;350:764-6. (Pubitemid 27387203)
184. Morris DL, Montgomery SM, Thompson NP, et al. Measles vaccination and inflammatory bowel disease: a national British Cohort Study. Am J Gastroenterol 2000;95:3507-12.
185. Davis RL, Kramarz P, Bohlke K, et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med 2001;155:354-9. (Pubitemid 32199182)
186. Bernstein CN, Rawsthorne P, Blanchard JF. Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease. Inflamm Bowel Dis 2007;13:759-62. (Pubitemid 46909992)
187. Molodecky NA, Panaccione R, Ghosh S, et al. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases 1. Inflamm Bowel Dis 2011;17:1792-9.
188. Bernstein CN. Assessing environmental risk factors affecting the inflammatory bowel diseases: a joint workshop of the Crohn's & Colitis Foundations of Canada and the USA. Inflamm Bowel Dis 2008;14:1139-46.
189. Sands BE. Within you, without you: is gastroenterology ready to embrace the "exposome"? Gastroenterology 2012;142:1403-4.
190. Rappaport SM, Smith MT. Epidemiology. Environment and disease risks. Science 2010;330:460-1.
191. Rappaport SM. Implications of the exposome for exposure science. J Expo Sci Environ Epidemiol 2011;21:5-9.
192. Patel CJ, Bhattacharya J, Butte AJ. An environment-wide association study (EWAS) on type 2 diabetes mellitus. PLoS One 2010;5:e10746.
193. Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol 1995;30(Suppl. 8):5-8.
194. Yamamoto T, Nakahigashi M, Saniabadi AR. Review article: diet and inflammatory bowel disease-epidemiology and treatment. Aliment Pharmacol Ther 2009;30:99-112.
195. Sonnenberg A. Geographic and temporal variations of sugar and margarine consumption in relation to Crohn's disease. Digestion 1988;41:161-71. (Pubitemid 19048309)
196. Hart AR, Luben R, Olsen A, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion 2008;77:57-64. (Pubitemid 351552979)
197. John S, Luben R, Shrestha SS, et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol 2010;22:602-6.